Immune determinants of COVID-19 disease presentation and severity
- 13 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 27 (1), 28-33
- https://doi.org/10.1038/s41591-020-01202-8
Abstract
COVID-19, caused by SARS-CoV-2 infection, is mild to moderate in the majority of previously healthy individuals, but can cause life-threatening disease or persistent debilitating symptoms in some cases. The most important determinant of disease severity is age, with individuals over 65 years having the greatest risk of requiring intensive care, and men are more susceptible than women. In contrast to other respiratory viral infections, young children seem to be less severely affected. It is now clear that mild to severe acute infection is not the only outcome of COVID-19, and long-lasting symptoms are also possible. In contrast to severe acute COVID-19, such ‘long COVID’ is seemingly more likely in women than in men. Also, postinfectious hyperinflammatory disease has been described as an additional outcome after SARS-CoV-2 infection. Here I discuss our current understanding of the immunological determinants of COVID-19 disease presentation and severity and relate this to known immune-system differences between young and old people and between men and women, and other factors associated with different disease presentations and severity.This publication has 95 references indexed in Scilit:
- Usefulness of the neutrophil-to-lymphocyte ratio to prediction of type 2 diabetes mellitus in morbid obesityDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2015
- Virus-Specific CD4+ Memory-Phenotype T Cells Are Abundant in Unexposed AdultsImmunity, 2013
- Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the ElderlyImmunity, 2012
- Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5Nature Immunology, 2011
- The Xs and Y of immune responses to viral vaccinesThe Lancet Infectious Diseases, 2010
- Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort studyBMJ, 2006
- TLR7 Ligands Induce Higher IFN-α Production in FemalesThe Journal of Immunology, 2006
- Inhibition of Beta Interferon Induction by Severe Acute Respiratory Syndrome Coronavirus Suggests a Two-Step Model for Activation of Interferon Regulatory Factor 3Journal of Virology, 2005
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Both age and gender affect thymic output: more recent thymic migrants in females than males as they ageClinical and Experimental Immunology, 2001